News | July 10, 2024
Lilly to acquire Morphic to improve outcomes for patients with inflammatory bowel disease
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
KIMS already have a multi-specialty hospital and gastro unit at Vizag
The Unit has been issued GMP Certification from ANVISA-Brazil
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Shares and American Depositary Shares of Olink for $26.00 per Share
Subscribe To Our Newsletter & Stay Updated
